🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
1812 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Nanning, Chengdu, Beijing, Dalian, Guangzhou, Hangzhou, Harbin, Kunming
2012-01
Recruiting
Chinese Atrial Fibrillation Registry
NCT06987825Atrial Fibrillation (AF)
Beijing Anzhen Hospital
Observational
100,000
Beijing, Hangzhou
2011-08-01
Recruiting
Cognitive Impairment, Retinopathy, and Cerebrovascular Lesions in the Elderly
NCT03542734Cerebral Small Vessel Diseases, Retinopathy, Cognitive Dysfunction
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,000
Hangzhou
2010-01-01
Recruiting
Comparison Influence to Prognosis of CTP and MRP in AIS Patients
NCT03367286Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,000
Hangzhou
2009-06-30
Active, closed
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
NCT00781612Neoplasm Metastasis
Genentech, Inc.
Phase 2
378
Beijing, Changchun, Guangzhou, Hangzhou, Harbin, Nanjing, Shanghai
2008-10-16
Active, closed
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
NCT04715802Breast, Mammaplasty, Breast Reconstruction
First Affiliated Hospital of Zhejiang University
Observational
240
Hangzhou
2006-10-18
Recruiting
Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease
NCT04965558Clinical Features and Outcome
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,000
Hangzhou
2004-01-01
Recruiting
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
NCT04965545Wilson Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,000
Hangzhou
2004-01-01
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742Fabry Disease
Genzyme, a Sanofi Company
Observational
9,000
Beijing, Hangzhou, Jinan, Nanjing, Shanghai
2001-07-31
Recruiting
The Jiaxing Birth Cohort in China
NCT03217656Childhood Obesity, Anemia, Pregnancy Complications, Pregnancy; Hypertension
Zhejiang University
Observational
500,000
Hangzhou
1999-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Beijing, Guangzhou, Hangzhou, Nanjing, Shanghai
1991-04-01
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Beijing, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming
1983-01
Rows per page Showing 1801–1812 of 1812
Previous 17 18 19
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou?page=19

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.